Energenesis Biomedical CO.,LTD. (6657.TW)

TWD 51.8

(-4.25%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 7.15 Million 7.35 Million 7.48 Million 7.08 Million 6.25 Million
Cost of Revenue 1.93 Million 2.18 Million 2.13 Million 2.25 Million 2.38 Million
Gross Profit 5.22 Million 5.16 Million 5.35 Million 4.82 Million 3.86 Million
Operating Expenses 267.06 Million 276.81 Million 127.44 Million 138.41 Million 157.1 Million
Selling, General and Administrative Expenses 81.93 Million 63.13 Million 65.69 Million 65.97 Million 58.92 Million
Research and Development Expenses 185.12 Million 213.68 Million 61.75 Million 72.43 Million 98.17 Million
Other Expenses - 2.27 Million -272 Thousand 1.05 Million 1.37 Million
Cost and Expenses 268.99 Million 279 Million 129.57 Million 140.66 Million 159.48 Million
Operating Income -261.83 Million -265.45 Million -119.95 Million -129.12 Million -149.19 Million
Interest Expense - 209 Thousand 284 Thousand 350 Thousand 578 Thousand
Income Tax Expense - - - - -
Earnings before Tax -260.38 Million -265.66 Million -120.23 Million -129.47 Million -149.77 Million
Net Income -260.38 Million -265.66 Million -120.23 Million -129.47 Million -149.77 Million
Earnings Per Share Basic -3.62 -3.99 -2.00 -2.19 -2.84
Earnings Per Share Diluted -3.62 -3.99 -2.00 -2.19 -2.84
Weighted Average Shares Outstanding 72.01 Million 66.63 Million 60.05 Million 59.06 Million 52.74 Million
Weighted Average Shares Outstanding (Diluted) 72.01 Million 66.63 Million 60.05 Million 59.06 Million 52.74 Million
Gross Margin 0.73 0.70 0.72 0.68 0.62
EBIT Margin -34.17 -32.79 -12.96 -15.42 -21.01
Profit Margin -36.38 -36.14 -16.06 -18.29 -23.96
EBITDA -244.57 Million -241.04 Million -97.05 Million -109.15 Million -131.33 Million
Earnings Before Tax Margin -36.58 -36.11 -16.02 -18.24 -23.87

Income Statement Charts